Predictor for Histological Microvascular Invasion of Hepatocellular Carcinoma: A Lesson from 229 Consecutive Cases of Curative Liver Resection

被引:140
作者
Eguchi, Susumu [1 ]
Takatsuki, Mitsuhisa [1 ]
Hidaka, Masaaki [1 ]
Soyama, Akihiko [1 ]
Tomonaga, Tetsuo [1 ]
Muraoka, Izumi [1 ]
Kanematsu, Takashi [1 ]
机构
[1] Nagasaki Univ, Grad Sch Biomed Sci, Dept Surg, Nagasaki 8528501, Japan
关键词
RISK-FACTORS; TRANSPLANTATION; RECURRENCE;
D O I
10.1007/s00268-010-0424-5
中图分类号
R61 [外科手术学];
学科分类号
摘要
Microscopic vascular invasion is an important risk factor for recurrent hepatocellular carcinoma (HCC), even after curative liver resection or orthotopic liver transplantation. To predict microscopic portal venous invasion, the following two questions were examined retrospectively: Is it possible to detect microvascular invasion preoperatively? What are the characteristics of a group of early HCC recurrences even with no microvascular invasion? Study 1 included 229 patients with HCC who underwent curative liver resection between 1991 and 2008; 127 had HCC without microscopic portal venous invasion, and 52 had HCC with microscopic portal venous invasion (MPVI). These two distinct groups were analyzed with regard to various clinicopathologic factors. Subsequently, we specifically investigated if HCCs < 5 cm with vascular invasion (n = 32) have some characteristics that would allow detection of latent microvascular invasion. Study 2 included 127 HCC patients without MVPI; 42 had a recurrence within 2 years, and 85 patients were recurrence-free for at least 2 years. These two distinct groups were analyzed with regard to various clinicopathologic factors. HCC diameter of > 5 cm, the macroscopic appearance of HCC, and high levels of preoperative des-gamma-carboxyprothrombin are significant prognostic factors in identifying microvascular invasion of HCC. The strongest predictor of early recurrence (within 2 years) was the serum alpha-fetoprotein level in patients without clear microvascular invasion. Tumor size, macroscopic appearance, and high tumor marker levels are important elements in identifying the group of patients with a low HCC recurrence rate after curative liver resection.
引用
收藏
页码:1034 / 1038
页数:5
相关论文
共 11 条
  • [1] LIVER RESECTION VERSUS TRANSPLANTATION FOR HEPATOCELLULAR-CARCINOMA IN CIRRHOTIC-PATIENTS
    BISMUTH, H
    CHICHE, L
    ADAM, R
    CASTAING, D
    DIAMOND, T
    DENNISON, A
    [J]. ANNALS OF SURGERY, 1993, 218 (02) : 145 - 151
  • [2] Multicentric occurrence and spread of hepatocellular carcinoma in whole explanted end-stage liver
    Hidaka, Masaaki
    Eguchi, Susumu
    Okudaira, Sadayuki
    Takatsuki, Mitsuhisa
    Tokai, Hirotaka
    Soyama, Akihiko
    Nagayoshi, Shigeki
    Mochizuki, Satoshi
    Hamasaki, Koji
    Tajima, Yoshitsugu
    Kanematsu, Takashi
    [J]. HEPATOLOGY RESEARCH, 2009, 39 (02) : 143 - 148
  • [3] HEPATIC RESECTION VERSUS TRANSPLANTATION FOR HEPATOCELLULAR-CARCINOMA
    IWATSUKI, S
    STARZL, TE
    SHEAHAN, DG
    YOKOYAMA, I
    DEMETRIS, AJ
    TODO, S
    TZAKIS, AG
    VANTHIEL, DH
    CARR, B
    SELBY, R
    MADARIAGA, J
    [J]. ANNALS OF SURGERY, 1991, 214 (03) : 221 - 229
  • [4] Risk factors for immediate post-operative fatal recurrence after curative resection of hepatocellular carcinoma
    Kim, Bong-Wan
    Kim, Young-Bae
    Wang, Hee-Jung
    Kim, Myung-Wook
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2006, 12 (01) : 99 - 104
  • [5] FORMULATION AND APPLICATION OF A NUMERICAL SCORING SYSTEM FOR ASSESSING HISTOLOGICAL ACTIVITY IN ASYMPTOMATIC CHRONIC ACTIVE HEPATITIS
    KNODELL, RG
    ISHAK, KG
    BLACK, WC
    CHEN, TS
    CRAIG, R
    KAPLOWITZ, N
    KIERNAN, TW
    WOLLMAN, J
    [J]. HEPATOLOGY, 1981, 1 (05) : 431 - 435
  • [6] Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis
    Mazzaferro, V
    Regalia, E
    Doci, R
    Andreola, S
    Pulvirenti, A
    Bozzetti, F
    Montalto, F
    Ammatuna, M
    Morabito, A
    Gennari, L
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (11) : 693 - 699
  • [7] Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters
    Roayaie, S
    Frischer, JS
    Emre, SH
    Fishbein, TM
    Sheiner, PA
    Sung, M
    Miller, CM
    Schwartz, ME
    [J]. ANNALS OF SURGERY, 2002, 235 (04) : 533 - 539
  • [8] The role of macroscopic classification in nodular-type hepatocellular carcinoma
    Shimada, M
    Rikimaru, T
    Hamatsu, T
    Yamashita, Y
    Terashi, T
    Taguchi, K
    Tanaka, S
    Shirabe, K
    Sugimachi, K
    [J]. AMERICAN JOURNAL OF SURGERY, 2001, 182 (02) : 177 - 182
  • [9] The predictors of microvascular invasion in candidates for liver transplantation with hepatocellular carcinoma - With special reference to the serum levels of des-gamma-carboxy prothrombin
    Shirabe, Ken
    Itoh, Shinji
    Yoshizumi, Tomoharu
    Soejima, Yuji
    Taketomi, Akinobu
    Aishima, Shin-Ichi
    Maehara, Yoshihiko
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2007, 95 (03) : 235 - 240
  • [10] Liver Transplantation for Hepatocellular Carcinoma Under Calcineurin Inhibitors Reassessment of Risk Factors for Tumor Recurrence
    Vivarelli, Marco
    Cucchetti, Alessandro
    La Barba, Giuliano
    Ravaioli, Matteo
    Del Gaudio, Massimo
    Lauro, Augusto
    Grazi, Gian Luca
    Pinna, Antonio Daniele
    [J]. ANNALS OF SURGERY, 2008, 248 (05) : 857 - 862